GAM Systematic’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-381
Closed -$27K 641
2016
Q4
$27K Buy
381
+270
+243% +$21.2K 0.01% 576
2016
Q3
$10K Buy
+111
New +$9.67K ﹤0.01% 607
2015
Q3
Sell
-13,466
Closed -$998K 641
2015
Q2
$998K Sell
13,466
-6,126
-31% -$468K 0.13% 256
2015
Q1
$1.53M Sell
19,592
-9,857
-33% -$747K 0.21% 199
2014
Q4
$2.13M Buy
+29,449
New +$2.05M 0.43% 76

Other funds holding MDT

GAM Systematic's MDT Position: Q1 2017 in Review

GAM Systematic sold out of Medtronic (MDT) in Q1 2017, closing a stake of 381 shares — an estimated $27K sold.

GAM Systematic first reported a position in MDT in Q4 2014 and held it in 5 quarters. The position peaked at $2.13M in Q4 2014. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

  • GAM Systematic reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
  • GAM Systematic sold 381 Medtronic shares in Q1 2017, an estimated $27K.
  • GAM Systematic first reported a position in Medtronic in Q4 2014 and held it in 5 quarters.
  • GAM Systematic's Medtronic position peaked at $2.13M in Q4 2014.
  • 1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on GAM Systematic's 13F filing for Q1 2017, filed 15 May 2017.